How D. was paid
$2.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| Steven C. Quay, M.D., Ph. D.Chairman, President and Chief Executive Officer | $730,961 | $1,482,695 | $250,000 | $39,200 | $2,502,856 |
| Mark J. DanielChief Financial Officer | $72,516 | $456,109 | — | $7,864 | $536,489 |
| Heather Rees, CPA (Inactive)Former Chief Financial Officer | $482,217 | $415,918 | — | $83,589 | $981,724 |
What changed and why
- $2.5MCEO total compensation decreased to $2,502,856 in fiscal 2025 from $2,764,082 in fiscal 2024.
- $250KDr. Quay received an annual performance bonus of $250,000 for fiscal 2025, down from $529,433 in 2024.
- Mark J. Daniel joined the company as Chief Financial Officer effective October 14, 2025.
- Heather Rees stepped down as Chief Financial Officer on October 14, 2025.
- $1.5MOption awards for Dr. Quay were valued at $1,482,695 for fiscal 2025 based on ASC 718.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.